Zynex, Inc. ( ZYXI ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call.
Zynex Inc (NASDAQ:ZYXI) said on Friday it has hired financial advisory firm Province LLC and formed a special board committee to evaluate a range of strategic alternatives. The company said Province will assist in reviewing options that include potential capital-raising, recapitalization and restructuring strategies.
Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Steven Lewis Dyson CEO | NASDAQ (NGS) Exchange | 98986M103 CUSIP |
| US Country | 1,000 Employees | 21 Jan 2022 Last Dividend | 5 Jan 2022 Last Split | 31 Dec 2002 IPO Date |
Zynex, Inc., established in 1996 and headquartered in Englewood, Colorado, is a prominent company that specializes in designing, manufacturing, and marketing innovative medical devices aimed at treating chronic and acute pain, as well as facilitating muscle rehabilitation. Through its subsidiaries, Zynex has developed a reputation for creating devices that use electrical stimulation to aid in pain management and muscle activation. The company’s commitment to improving patient outcomes is evident through its diverse product portfolio, which caters to a wide range of medical needs, including pain management, stroke and spinal cord injury rehabilitation, and hemodynamic monitoring. Zynex's approach to the market involves direct sales primarily in the United States, utilizing a team of dedicated field sales representatives to engage with physicians and therapists.